Molecule Structure

Scientific Name

Imiquimod

Description of the Drug

Imiquimod is a toll-like receptor 7 agonist used to treat non hyperkeratotic, non hypertrophic actinic keratosis, basal cell carcinoma, genital or perianal warts, and condyloma acuminata.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00724

Brand Name(s)

Aldara, Imiquimod, Zyclara

Company Owner(s)

Apotex Inc, Glenmark Generics Inc Usa, Fougera Pharmaceuticals Inc, Anda Repository Llc, Padagis Israel Pharmaceuticals Ltd, Taro Pharmaceutical Industries Ltd, Strides Pharma Global Pte Ltd, Cosette Pharmaceuticals Inc, Bausch Health Us Llc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Toll-like receptor 7 SINGLE PROTEIN AGONIST CHEMBL5936

Unichem Links

SureChEMBL SCHEMBL26136
PharmGKB PA449972
Human Metabolome Database HMDB0014862
DrugBank DB00724
PubChem: Thomson Pharma 14749564
PubChem 57469
Mcule MCULE-9421195760
LINCS LSM-5408
Nikkaji J501.447F
PDBe 6T0
BindingDB 50240849
EPA CompTox Dashboard DTXSID7041047
DrugCentral 1429
ChemicalBook CB9257146 CB2664655
Guide to Pharmacology 5003
rxnorm ALDARA IMIQUIMOD ZYCLARA
PubChem: Drugs of the Future 12013659
ChEBI 36704
ZINC ZINC000019632912